The U.S. Food and Drug Administration has given 23andMe clearance to begin selling kits for_the genetic testing of_Bloom Syndrome. This is a rare recessive gene disorder that is characterized by shorter height and a predisposition to develop_cancer. Parents of children with Bloom Syndrome don’t exhibit any symptoms of the disorder. 23andMe’s direct-to-consumer genetic test… Read More